Immunotherapy in Malignant Pleural Mesothelioma

Immunotherapy in Malignant Pleural Mesothelioma

The only registered systemic treatment for malignant pleural mesothelioma (MPM) is platinum based chemotherapy combined with pemetrexed, with or without bevacizumab. Immunotherapy did seem active in small phase II trials. In this review, we will highlight the most important immunotherapy-based resea...

Full description

Bibliographic Details
Main Authors: Cornedine J. de Gooijer, Frank J. Borm, Arnaud Scherpereel, Paul Baas
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-02-01
Series:Frontiers in Oncology
Subjects:
immunotherapy
malignant pleural mesothelioma
angiogenesis inhibitors
PD-L1
dendritic cell therapy
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.00187/full

Similar Items

Similar Items